Sun Pharma to acquire Organon for $14 per share in $11.75 billion deal Apr 26, 2026 07:51PM
Sun Pharma signs Definitive Agreement to Acquire Organon Apr 26, 2026 07:51PM
OGN DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - Jul 21, 2025 06:06PM
OGN DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - Jul 20, 2025 04:57PM
OGN DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OGN Jul 19, 2025 04:52PM
View Older Stories

Jul 18, 2025 04:47PM OGN FINAL DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action -
Jul 17, 2025 04:42PM OGN DEADLINE: ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OGN
Jul 16, 2025 04:37PM OGN DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OGN
Jul 15, 2025 02:59PM OGN DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - O
Jul 14, 2025 02:54PM OGN DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OGN
Jul 13, 2025 01:14PM OGN FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Action - OG
Jul 12, 2025 12:28PM OGN IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Ac
Jul 11, 2025 11:41AM OGN FINAL DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Organon & Co. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 22 Deadline in Securities Class Acti
Jul 9, 2025 05:41PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jul 6, 2025 05:08PM ROSEN, A TOP RANKED LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jul 5, 2025 05:03PM ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jul 4, 2025 04:58PM ROSEN, A LONGSTANDING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jul 3, 2025 03:58PM ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jul 2, 2025 03:53PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 30, 2025 07:02PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 29, 2025 10:18AM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 27, 2025 11:59AM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 25, 2025 10:48PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 24, 2025 10:43PM ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 23, 2025 06:26PM ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 22, 2025 02:06PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 20, 2025 07:20PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 19, 2025 07:15PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 18, 2025 07:10PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 17, 2025 07:05PM ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 15, 2025 03:11PM ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 14, 2025 03:06PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 13, 2025 03:01PM ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 10, 2025 09:34PM ROSEN, A LONGSTANDING FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 9, 2025 11:56AM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 7, 2025 11:02AM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 6, 2025 10:56AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Jun 2, 2025 12:09PM ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
May 31, 2025 01:16PM ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
May 27, 2025 07:34AM Organon (OGN) and Samsung Bioepis Granted FDA Interchangeability Designation
May 27, 2025 07:30AM US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
May 1, 2025 07:00AM Organon Reports Results for the First Quarter Ended March 31, 2025
Apr 15, 2025 05:01PM Organon (OGN) Appoints Ramona A. Sequeira to its Board
Apr 15, 2025 05:00PM Organon Appoints Ramona A. Sequeira to the Company’s Board of Directors
Apr 15, 2025 07:31AM Organon To Report First Quarter 2025 Results and Host Conference Call on May 1, 2025
Apr 1, 2025 07:31AM Organon (OGN) Acquires TOFIDENCE
Apr 1, 2025 07:30AM Organon Acquires TOFIDENCE™ (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA® (tocilizumab) Injection, for Intravenous Infusion in the U.S.
Mar 28, 2025 06:00AM European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
Mar 8, 2025 09:00AM New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Old
Feb 13, 2025 07:30AM Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2024
Jan 23, 2025 07:30AM Organon To Report Fourth Quarter and Full Year 2024 Results and Host Conference Call on February 13, 2025
Dec 19, 2024 07:30AM Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 16, 2024 07:30AM Organon (OGN) Announces FDA Approval of VTAMA cream
Dec 16, 2024 07:30AM FDA Approves VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
Nov 5, 2024 07:29AM Organon (OGN) Issues Update on FDA Review of VTAMA Cream
View Older Stories